Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1993 | 12-1992 | 12-1991 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | -1,619 | -734 | -399 |
| Depreciation Amortization | N/A | N/A | 309 | 137 | 159 |
| Other Working Capital | N/A | N/A | 356 | 1,881 | 712 |
| Other Operating Activity | 0 | 0 | 504 | 0 | 0 |
| Operating Cash Flow | $N/A | $N/A | $-451 | $1,284 | $472 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -1,401 | -42 | -60 |
| Other Investing Activity | 0 | 0 | 0 | -1,242 | -412 |
| Investing Cash Flow | $N/A | $N/A | $-1,401 | $-1,284 | $-472 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | 6,916 | 0 | 0 |
| Financing Cash Flow | $N/A | $N/A | $6,916 | $N/A | $N/A |
| End Cash Position | N/A | N/A | 5,064 | N/A | N/A |
| Net Cash Flow | $N/A | $N/A | $5,064 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | N/A | -451 | 1,284 | 472 |
| Free Cash Flow | 0 | 0 | -451 | 1,284 | 472 |